Back to results
US 2008/0305173 A1Published application
Amorphous drug beads
OwnerBeuford Arlie Bogueinventor
Life of this patent
Estimating the term…
Abstract
The present inventive subject matter relates to amorphous drug beads comprising an amorphous active drug and an organic surfactant having improved solubility, absorption and wettability characteristics. The present inventive subject matter further relates to methods of preparing the amorphous drug beads, wherein molten drug beads are subject to a cooling step with or without shear.
Claims20
A method of making an amorphous drug bead coated with an organic surfactant, the method comprising:
- a) providing an amorphous active drug having a particular particle size and a molten organic surfactant;
- b) melting said amorphous active drug in the presence of said molten organic surfactant;
- c) allowing said melted amorphous active drug and said molten organic surfactant to form two phases;
- d) subjecting said two phases to high shear to form an emulsion;
- and
- e) cooling said emulsion to solidify said amorphous active drug to form an amorphous drug bead;
- wherein said melted amorphous active drug is insoluble in and not miscible with said melted organic surfactant and said amorphous drug bead has a particle size of about 90 nm to about 10 microns.
4 more elements
(canceled)
(canceled)
(canceled)
(canceled)
An amorphous drug bead, prepared according to a method comprising the steps of:
- a) providing an amorphous active drug having a particular particle size and a molten organic surfactant;
- b) melting said amorphous active drug in the presence of said molten organic surfactant;
- c) allowing said melted amorphous active drug and said molten organic surfactant to form two phases;
- d) subjecting said two phases to high shear to form an emulsion;
- and
- e) cooling quenching said emulsion to solidify said amorphous active drug to form an amorphous drug bead;
- wherein said melted amorphous active drug is insoluble in and not miscible with said melted organic surfactant;
- wherein and said amorphous drug bead has a particle size of about 90 nm to about 10 microns.
5 more elements
Dependencies are inferred from the claim text.